CLINICAL_TRIALS
trial_result
· 2016-12-07
Clinical Trial Update: Gemcitabine in Treating Patients With Recurrent Chronic Lymphocytic Leukemia [Phase 2]
Summary
A Phase 2 trial evaluating gemcitabine in patients with recurrent chronic lymphocytic leukemia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Leukemia | Phase 2 | Status: COMPLETED